Search

everythinglearnresearchcommunity

for

Search:↓

Modified stem cells from umbilical cord blood can make hair grow faster.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

Current hair regeneration methods show promise but face challenges in maintaining cell effectiveness and creating the right environment for hair growth.

Both human platelet lysate and minoxidil can promote hair growth, but they affect different genes and cell survival rates.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

More research is needed to understand how testosterone is maintained in adult males.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Fully regenerating human hair follicles not yet achieved.